Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors Associated with Failure to Achieve SVR in Hepatitis C Genotype 3 Patients Within an Integrated Care Delivery System.

Journal of managed care & specialty pharmacy - 1 Aug 2015

Cheetham T Craig, Niu Fang, Chiang Kevin, Yuan Yong, Kalsekar Anu, Hechter Rulin, Hay Joel W, Nyberg Lisa

Abstract excerpt

BACKGROUND: Achievement of sustained virologic response (SVR) and factors associated with treatment failure in hepatitis C virus (HCV) genotype 3 have been described in tertiary and referral care settings, with rates of SVR reported to range between 72% and 89%. Fewer data exist on SVR outside of these settings. OBJECTIVE: To describe rates of SVR and characterize factors associated with achievement of SVR within...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to California
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C

Share to Interferon-alpha

Share to Multivariate Analysis

Share to Ribavirin

Share to Treatment Failure

Source

Open in PubMed Open full text

Identifiers

PMID: 26233536
DOI: 10.18553/jmcp.2015.21.8.641
PMCID: PMC10398146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors Associated with Failure to Achieve SVR in Hepatitis C Genotype 3 Patients Within an Integrated Care Delivery System.PMID 26233536Read ↗

Retrospective analysis of hepatitis C infected patients treated through an integrated care model.Semantic proximity Read ↗

Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients.Semantic proximity Read ↗

Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.Semantic proximity Read ↗

Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting.Semantic proximity Read ↗

Improving access to hepatitis C care for urban, underserved patients using a primary care-based hepatitis C clinic.Semantic proximity Read ↗

Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.Semantic proximity Read ↗

Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Semantic proximity Read ↗

Clinical characteristics, healthcare costs, and resource utilization in hepatitis C vary by genotype.Semantic proximity Read ↗

Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based StudySemantic proximity Read ↗

Quality of care in patients with chronic hepatitis C virus infection: a cohort study.Semantic proximity Read ↗

Predictors of response of US veterans to treatment for the hepatitis C virus.Semantic proximity Read ↗

Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.